Two Sigma Investments’s Cantel Medical Corporation CMD Stock Holding History

Two Sigma Investments’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-99,127	Closed	-$7.91M	–	4799
2021 Q1	$7.91M	Buy	+99,127	New	+$7.74M	0.02%	816
2020 Q3	–	Sell	-37,021	Closed	-$1.64M	–	3746
2020 Q2	$1.64M	Buy	+37,021	New	+$1.38M	0.01%	1203
2018 Q4	–	Sell	-24,136	Closed	-$2.22M	–	3695
2018 Q3	$2.22M	Buy	+24,136	New	+$2.3M	0.01%	1404
2016 Q3	–	Sell	-22,010	Closed	-$1.51M	–	3472
2016 Q2	$1.51M	Buy	+22,010	New	+$1.52M	0.01%	1456
2015 Q3	–	Sell	-5,555	Closed	-$298K	–	2900
2015 Q2	$298K	Buy	+5,555	New	+$270K	﹤0.01%	2431
2015 Q1	–	Sell	-13,651	Closed	-$591K	–	2947
2014 Q4	$591K	Buy	+13,651	New	+$558K	﹤0.01%	1646

Two Sigma Investments's CMD Position: Q2 2021 in Review

Two Sigma Investments sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 99,127 shares — an estimated $7.91M sold.

Two Sigma Investments first reported a position in CMD in Q4 2014 and held it in 6 quarters. The position peaked at $7.91M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Two Sigma Investments reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Two Sigma Investments sold 99,127 Cantel Medical Corporation shares in Q2 2021, an estimated $7.91M.
Two Sigma Investments first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 6 quarters.
Two Sigma Investments's Cantel Medical Corporation position peaked at $7.91M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.